Strategic Partnerships BioSkryb already collaborates with Eremid CSP and regional distributors like Research Instruments Pte Ltd, plus Tecan for scalable workflow, creating ready channels to commercialize ResolveDNA and ResolveOME. These partnerships, together with the Early Access Program, offer direct paths to pilots, broader regional reach, and recurring services through CSP networks.

Automation Demand The collaboration with Tecan to enable high throughput library preparation signals strong demand for scalable single cell workflows. Sales plays can focus on automation friendly core kits and integration with automated liquid handling to support labs expanding to multiomic single cell analyses.

Compliance Advantage HIPAA aligned technology and a focus on single cell multiomics position BioSkryb to engage clinical labs and hospital researchers seeking compliant data workflows. Target pilots in clinical research and develop future offerings that meet regulatory expectations.

Growth Momentum Venture backed growth with revenue in the mid range and funding support underpins expansion plans. The Early Access Program for ResolveSEQ LongRead and HCA partnerships provide concrete entry points for multi year procurement, service contracts, and co development opportunities.

Multiomic Leadership Core kit configurations for ResolveDNA and ResolveOME enabling eight hour workflows, plus a forthcoming long read solution, position BioSkryb as a leader in single cell multiomics. This opens cross selling to researchers expanding to long read and multiomic analyses and potential collaborations with large consortia.